These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 7911400

  • 1. Treatment of gastroesophageal (acid) reflux with lansoprazole: an overview.
    Dobrilla G, Di Fede F.
    Clin Ther; 1993; 15 Suppl B():2-13. PubMed ID: 7911400
    [Abstract] [Full Text] [Related]

  • 2. pH, healing rate, and symptom relief in patients with GERD.
    Huang JQ, Hunt RH.
    Yale J Biol Med; 1999; 72(2-3):181-94. PubMed ID: 10780580
    [Abstract] [Full Text] [Related]

  • 3. Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer.
    Florent C.
    Clin Ther; 1993; 15 Suppl B():14-21. PubMed ID: 7911399
    [Abstract] [Full Text] [Related]

  • 4. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
    Sontag SJ, Kogut DG, Fleischmann R, Campbell DR, Richter J, Robinson M, McFarland M, Sabesin S, Lehman GA, Castell D.
    Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463
    [Abstract] [Full Text] [Related]

  • 5. Long-term management of gastroesophageal reflux disease and its complications.
    Richter JE.
    Am J Gastroenterol; 1997 Apr; 92(4 Suppl):30S-34S; discussion 34S-35S. PubMed ID: 9127624
    [Abstract] [Full Text] [Related]

  • 6. Duodenal ulcer and gastroesophageal reflux disease today: long-term therapy--a sideways glance.
    Bardhan KD.
    Yale J Biol Med; 1996 Apr; 69(3):211-24. PubMed ID: 9165690
    [Abstract] [Full Text] [Related]

  • 7. Pharmacological and pharmacodynamic essentials of H(2)-receptor antagonists and proton pump inhibitors for the practising physician.
    Huang JQ, Hunt RH.
    Best Pract Res Clin Gastroenterol; 2001 Jun; 15(3):355-70. PubMed ID: 11403532
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease.
    Hatlebakk JG, Berstad A.
    Clin Pharmacokinet; 1996 Nov; 31(5):386-406. PubMed ID: 9118586
    [Abstract] [Full Text] [Related]

  • 9. Treatment of reflux esophagitis resistant to H2-receptor antagonists with lansoprazole, a new H+/K(+)-ATPase inhibitor: a controlled, double-blind study. Lansoprazole Study Group.
    Feldman M, Harford WV, Fisher RS, Sampliner RE, Murray SB, Greski-Rose PA, Jennings DE.
    Am J Gastroenterol; 1993 Aug; 88(8):1212-7. PubMed ID: 8101695
    [Abstract] [Full Text] [Related]

  • 10. Daily low-dose versus alternate day full-dose lansoprazole in the maintenance treatment of reflux esophagitis.
    Baldi F, Morselli-Labate AM, Cappiello R, Ghersi S, Italian Lansoprazole Study Group.
    Am J Gastroenterol; 2002 Jun; 97(6):1357-64. PubMed ID: 12094850
    [Abstract] [Full Text] [Related]

  • 11. Management of heartburn in a large, randomized, community-based study: comparison of four therapeutic strategies.
    Howden CW, Henning JM, Huang B, Lukasik N, Freston JW.
    Am J Gastroenterol; 2001 Jun; 96(6):1704-10. PubMed ID: 11419818
    [Abstract] [Full Text] [Related]

  • 12. The medical management of reflux esophagitis. Role of antacids and acid inhibition.
    Sontag SJ.
    Gastroenterol Clin North Am; 1990 Sep; 19(3):683-712. PubMed ID: 1977703
    [Abstract] [Full Text] [Related]

  • 13. A placebo-controlled dose-ranging study of lansoprazole in the management of reflux esophagitis.
    Earnest DL, Dorsch E, Jones J, Jennings DE, Greski-Rose PA.
    Am J Gastroenterol; 1998 Feb; 93(2):238-43. PubMed ID: 9468251
    [Abstract] [Full Text] [Related]

  • 14. Proton pump inhibitors or histamine-2 receptor antagonists for the prevention of recurrences of erosive reflux esophagitis: a cost-effectiveness analysis.
    Harris RA, Kuppermann M, Richter JE.
    Am J Gastroenterol; 1997 Dec; 92(12):2179-87. PubMed ID: 9399748
    [Abstract] [Full Text] [Related]

  • 15. Lansoprazole: a comprehensive review.
    Zimmermann AE, Katona BG.
    Pharmacotherapy; 1997 Dec; 17(2):308-26. PubMed ID: 9085323
    [Abstract] [Full Text] [Related]

  • 16. Lansoprazole versus omeprazole in the treatment of reflux esophagitis.
    Vcev A, Stimac D, Vceva A, Rubinić M, Ivandić A, Ivanis N, Horvat D, Volarić M, Karner I.
    Acta Med Croatica; 1997 Dec; 51(3):171-4. PubMed ID: 9248117
    [Abstract] [Full Text] [Related]

  • 17. Efficacy, safety, and cost issues in managing patients with gastroesophageal reflux disease.
    Garnett WR.
    Am J Hosp Pharm; 1993 Apr; 50(4 Suppl 1):S11-8. PubMed ID: 8097363
    [Abstract] [Full Text] [Related]

  • 18. Lansoprazole compared with ranitidine for the treatment of nonerosive gastroesophageal reflux disease.
    Richter JE, Campbell DR, Kahrilas PJ, Huang B, Fludas C.
    Arch Intern Med; 2000 Jun 26; 160(12):1803-9. PubMed ID: 10871974
    [Abstract] [Full Text] [Related]

  • 19. Therapeutic approaches to healing esophagitis.
    Boyce HW.
    Am J Gastroenterol; 1997 Apr 26; 92(4 Suppl):22S-27S; discussion 27S-29S. PubMed ID: 9127623
    [Abstract] [Full Text] [Related]

  • 20. The role of omeprazole in healing and prevention of reflux disease.
    Klinkenberg-Knol EC.
    Hepatogastroenterology; 1992 Feb 26; 39 Suppl 1():27-30. PubMed ID: 1577392
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.